Grizzly Bulls LogoGrizzly BullsHow it WorksCalculator🚀 PremiumBlog
Log In

Grizzly Bulls’ Billionaires Index

⬅ # 460 Fred Smith|# 462 Niels Peter Louis-Hansen ➡

# 461 Jiang Rensheng 

$6.79B

Real Time Net Worth
as of 11/21/2024
-$300.7M (-4.43%)

# 461 Jiang Rensheng 

$6.79B

Real Time Net Worth
as of 11/21/2024
-$300.7M (-4.43%)
OccupationChair, Zhifei
Source of WealthVaccines
Age71
ResidenceChongqing, China
Marital StatusMarried
Children1
EducationAssociate in Arts/Science, Guilin Medical University
Age-Adjusted Net Worth$3.22B
Jiang Rensheng
Jiang Rensheng
China
Net worth: $6.79B

Self-Made Score 

Breitling Superocean Heritage II Automatic Chronometer 44 mm

Wealth History

Hover or tap to reveal net worth by year
Loading Chart

Biography

Early Life and Education

Born in 1953 in a remote village in the mountainous region of Guangxi, China.
During the Cultural Revolution, graduated from high school and taught in a primary school for seven years while also working in the fields to support himself.
Waited until 1977 for the restoration of the Gakao (college entrance exam) before finally graduating from Guilin Medical University.

Career Journey

Started his career at the Guanyang County Epidemic Health and Forecasting Center, quickly rising through the ranks.
Moved to Nanning, the provincial capital, and became Deputy Head of the Vaccination Unit and Head of the Biology Department.
At the age of 46, moved to Chengdu and entered the private sector by joining a vaccine company.
Discovered his entrepreneurial spirit by taking over a vaccine developer in Chongqing, marking the beginning of Zhifei Biological Product.

Zhifei Biological Product

Founded Zhifei Biological Product and became the sole distributor in China for the meningitis C vaccine, achieving early success.
Secured a distribution contract with Merck for the HPV vaccine, marking a significant milestone.
Diversified activities to include R&D, production, marketing, distribution, import, and export of biotech products and services.
Zhifei went public in 2010 in Shenzhen, becoming the first private vaccine company listed on ChiNext.
Achieved notable success in 2020, ranking among the top 10 Chinese fortunes.
Owns 20.5% of Zhifei.

Contributions and Philanthropy

Developed more than 10 vaccines against various diseases, contributing significantly to public health in China.
Donated RMB 10 million to Hubei province for pandemic control and regularly contributes to various associations, rural schools, and university libraries.
Upholds a philosophy of 'social benefits go before corporate profits.'

Personal Life

Lives in Chongqing, China, with his wife and child.
Started from humble beginnings, initially living on the premises of the company to reimburse manufacturers.
Maintained a serious reputation in the industry, leading to manufacturers offering favorable terms, such as extended payment periods and waiving down payments.

Chongqing Genrix Biopharmaceutical

Chaired the Shenzhen-listed vaccine firm Chongqing Zhifei Biological Products.
Won Chinese sales rights to Merck's HPV drug in 2018.
Took Chongqing Genrix Biopharmaceutical public in Shanghai in 2023.

Jiang Rensheng's Wealth is Equivalent to:

5,225,558 Herman Miller Aeron Chairs

Herman Miller Aeron Chair

1,284,390 Gold Bars (50 gram)

24K Solid 50g Gold Ingot

69,375 Tiny Homes

Tiny House, Two Bedroom Solar Prefab Home

How long would it take you to become as rich as Jiang Rensheng?

If you started with $10,000 and invested an additional $500 each month at a 43.43% CAGR, it would take you 5 years to reach Jiang Rensheng's net worth of $6.79B.

Is this realistic? It depends how closely the VIX-TA-Macro Advanced model performs to its history in the future. Since Grizzly Bulls launched on January 1, 2022, it's returned 58.67% compared to 23.91% for the S&P 500 benchmark.

Enter data in all but one field below, then calculate the missing value

Jiang Rensheng is very wealthy, but what's stopping you from reaching that same level of success? As summarized in our five fundamental rules to wealth building, becoming wealthy in a modern capitalist economy is not complicated. There's actually only three variables:

  1. Your starting capital
  2. Your earnings after expenses
  3. The compound annual growth rate (CAGR) of your savings

Most people start with zero or very little, so if you weren't born into wealth, don't fret! The majority of the fortunate folks listed in our Grizzly Bulls’ Billionaires Index came from middle class or lower backgrounds. The most distinguishing characteristic of the group is their ability to consistently earn a high CAGR on their savings.

Every billionaire has a unique strategy to achieve high CAGR. For Jiang Rensheng, Vaccines is the primary source. Whether you choose to invest your savings in your own businesses or the businesses of others is not as important. The salient piece of the puzzle is ensuring that your hard-earned savings are generating sufficient CAGR to reach your long term goals.

Most people simply invest their money in index funds and call it a day. There's nothing wrong with this approach, but it guarantees relative mediocrity. To achieve greatness, you need to invest your money to earn higher than average returns. In the long run, better investors will always finish ahead of better earners.

Source: Grizzly Bulls reporting

Methodology: Grizzly Bulls' Billionaires Index is a daily ranking of the world's billionaires and richest people. Grizzly Bulls strives to provide the most accurate net worth calculations available. We pull data from public equity markets, SEC filings, public real estate records, and other reputable sources.

The index is dynamic and updates daily at the close of U.S. stock market trading based on changes in the markets, economy, and updates to Grizzly Bulls' proprietary algorithm of personal wealth calculation. Stakes in public companies are tracked daily based on the relevant closing prices of the underlying securities. Additionally, stakes in private companies, cash, real estate, and other less easily valued assets are updated periodically through careful analysis of insider transactions, comparable public company sales / EBITDA multiples, etc.

Affiliate Disclosure: Some of the links on this page are affiliate links. This means that, at no additional cost to you, we may earn a commission if you click through and make a purchase. We only recommend products or services we believe will add value to our readers.

Edited by: Lee Bailey